microdosing glp-1 menopause THE PCCA BLOG MENOPAUSE & GLP1 MICRODOSING

Absalon Gutierrez, associate professor and endocrinologist at the University of Texas Health Houston, says constipation is the most common change in bowel habits he sees

The FDA and EMA have approved a number of GLP1 receptor agonists, but in this review, we will focus on those compounds that have been investigated preclinically, that is, exenatide, liraglutide, semaglutide and dulaglutide

Lilly is putting a commercial savings card program in place that will help people who may benefit from Zepbound better access it.

Turner is part of a growing cohort of men who are microdosing GLP-1s

Weve vetted the safest sources in our review of the best compounded tirzepatide providers

When GLP-1 drugs and other medicines are priced like a luxury and regulated like a fortress, people will find another door